Periodic Reporting for period 1 - ICECOUP (ICE coupling protein inhibitors)
Reporting period: 2024-03-15 to 2026-03-14
Regarding the role of MobBICE in vivo, it was investigated through genetic engineering followed by conjugation assays. It was demonstrated that MobBICE interacts with the relaxase (another protein involved in conjugation) of ICEEc1 to transfer a plasmid that carries the origin of transference (oriT) of ICEEc1. The TMDs of MobBICE are required for this function. In addition, preliminary data about the interaction between the oriT of the ICEEc1 and one of the native plasmids of E. coli ECOR31 was shown. The ability of MobBICE to substitute other T4CPs, such as those from the mobilisable plasmid CloDF13 and the conjugative plasmid R388 was analysed. It was determined that they cannot substitute for each other.
Finally, the study of the effect of potential inhibitors of MobBICE was started. First, a positive control targeting a different protein of the conjugation system used, linoleic acid, was analysed. A decrease in the mobilisation frequency was observed, but no significant results were obtained. Then, dinoprost was evaluated, and surprisingly, although the results were not statistically significant, it seeemed to have the opposite effect to what was expected.
Preliminary results of this project revealed that there is an interaction between the oriT of ICEEc1 and one of the conjugative plasmids present in the E. coli strain ECOR31. Nevertheless, no interaction was detected between the oriT, the relaxase and the T4CP of ICEEc1 and the equivalent elements of other MGE, such as the mobilisable plasmid CloDF13 or the conjugative plasmid R388. Defining the boundaries, characteristics and restrictions of these dynamic interactions is essential and, once more, underscores the necessity of experimental evidence besides genomic predictions to address complicated biological problems such as AR dissemination. A thorough characterization is also crucial for the identification and use of possible conjugation inhibitors. This project was also pioneer, as far as we know, in the use of a molecular component of an ICE as a target to control mobilization.
Overall, these results require further research to draw consistent conclusions. Nevertheless, ICECOUP has laid the foundation of a novel research line that will be continued within the host laboratory. In conclusion, this project has provided novel insights into the conjugation process of an ICE that in the long run can be used to design novel strategies to combat AR, such as the use of conjugation inhibitors targeting the T4CPs.